At a CAGR of 7.2% between 2022 and 2028, the global market for live cell imaging is anticipated to grow from 2021’s valuation of US$ 1,801.9 Mn to 2028’s valuation of US$ 2,921.9 Mn.
Live cell imaging is the study of cellular structure and function in living cells via microscopy. It is used to obtain a better understanding of biological function through the study of cellular dynamics. Live cell imaging is an important analytical tool used in laboratories to study biomedical research disciplines, such as neurobiology, pharmacology, cell biology, and developmental biology.
Rising disease prevalence and an expanding elderly population are driving significant expansion in the market for live cell imaging worldwide. An increase in the use of high-content screening methods in the pharmaceutical industry is also anticipated to fuel market expansion. However, the live cell imaging market is anticipated to be slowed by factors like the high price of high-content screening systems and a lack of skilled professionals.
Get Exclusive Sample PDF Copy of the Report @ https://www.coherentmarketinsights.com/insight/request-sample/1081
Market for live cell imaging worldwide: Regional Insights
North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa make up the five main regional submarkets of the market for live cell imaging worldwide.
Because cancer is becoming increasingly common in North America, particularly the United States, the region is projected to increase its market share at a faster rate than any other region during the forecast period. With the growing number of cancer cases in America, more researchers are turning to live cell imaging. To give just one example, the American Cancer Society predicts that in 2022 there will be a projected 1.9 Mn new cases of cancer diagnosed and 609,360 cancer-related deaths in the United States.
The increasing prevalence of chronic diseases (such as cancer, neurodegeneration, and cardiac diseases) and the subsequent increase in government funding are also expected to fuel rapid expansion of the market for live cell imaging worldwide in Europe. Research in cell and developmental biology is receiving an increasing amount of funding from organizations like Cancer Research UK and the Wellcome Trust. More people have access to the technology thanks to efforts by universities and private research institutes.
Market for live cell imaging worldwide Drivers
Over the forecast period, the market for live cell imaging worldwide is anticipated to grow due to the rising incidence of chronic diseases such as cancer, neurodegeneration, and cardiovascular disease. Due to the rising prevalence of chronic diseases and the corresponding need for rapid diagnostic methods, there has been a surge in interest in live cell imaging. The leading causes of death and disability in the United States, and a major factor in rising health care costs, are chronic diseases, and the Centers for Disease Control and Prevention (CDC) reports that six out of ten Americans have at least one chronic disease.
During the predicted time period, the market for live cell imaging worldwide is anticipated to grow thanks to an increase in the development and adoption of live cell imaging systems. For example, in May of 2020, CytoSMART Technologies announced the release of their new live-cell imaging system. Those conducting immediate, side-by-side comparisons of cell cultures will find the CytoSMART Lux2 Duo Kit to be a simple, cost-effective solution.
Market for live cell imaging worldwide: Opportunities
Participants in the live cell imaging market can anticipate significant growth opportunities due to the increasing use of live cell imaging in personalized medicines. For instance, Screen Holdings Co., Ltd. and PHC Corporation of North America entered into a partnership in September 2021 to distribute the Screen Cell imager series of live cell imaging systems across North America. Useful in cellular research, drug discovery, cosmetics, and biopharmaceuticals, incredibly precise non-invasive imaging of organoids and spheroids is now possible with the help of state-of-the-art imaging instruments.
Participants in the market for live cell imaging worldwide can anticipate significant growth opportunities as the demand for live cell imaging continues to rise. Metabolic engineers, for instance, are using live-cell microscopy imaging to investigate molecular dynamics in industrial microbes, as detailed in a study published in Trends in Biotechnology (Journal) in November 2021. More possibilities for live cell imaging will arise as a result of this.
Market for live cell imaging worldwide: Key Companies Insights
As a global industry, live cell imaging is fiercely competitive. This is due to the fact that high-content screening methods are becoming increasingly popular for use in the drug discovery process, and as a result, industry leaders are concentrating on the introduction of cutting-edge methods.
Thermo Fisher Scientific, Merck KgaA, PerkinElmer, Inc., Nikon Instruments, Inc., Live Cell Instrument, Olympus, Danaher, CytoSMART Technologies, ZEISS Group, Becton, Dickinson & Company, and ZEISS Group are just some of the major players in the market for live cell imaging worldwide.
Direct Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1081
Market for live cell imaging worldwide:Trends
The global ageing population is anticipated to be a major driver of the live cell imaging market. Cancer, neurodegeneration, and cardiovascular disease are just a few examples of chronic illnesses that need more attention as our population ages. The percentage of the world’s population that is 65 or older is projected to rise from 9.3 percent in 2020 to roughly 16.0 percent in 2050, according to the United Nations.
The live cell imaging market is predicted to expand as a result of the rising development of novel standalone systems. The CytoSMART Omni FL, developed by CytoSMART Technologies and released in April 2022, is a cutting-edge live-cell imaging analysis system that adds red and green fluorescence channels to the company’s flagship CytoSMART Omni product line.
Market for live cell imaging worldwide: Restraints
The global market for live cell imaging is anticipated to grow slowly due to a lack of qualified professionals. To fully grasp the potential of live cell imaging technology for studying cellular processes, one needs the expertise of trained experts. Thus, the lack of trained experts is likely to stifle the expansion of the global market for live cell imaging.
The global market for live cell imaging is anticipated to grow slowly due to the expensive nature of high-content screening systems. High-content screening systems (HCS) are expensive because they have sophisticated cell imaging and analysis features and functionalities. The price tag on a confocal microscope can easily exceed $200,000. HCS uses a GE Healthcare In-Cell 2000 Analyzer system, which can run you about $240,000.
Market for live cell imaging worldwide: Segmentation
The report on the global market for live cell imaging is broken down into those three sections: Product, Application, and Region.
The market is broken down into submarkets for hardware, consumables, and software and services. As a result of the increasing demand for standalone systems, the live cell imaging equipment market is predicted to grow at a faster rate than any other segment during the forecast period. What we call “standalone systems” are pieces of hardware that don’t need to be connected to or part of anything else in order to do their job.
It is anticipated that technological developments in live cell imaging software and services will lead to significant expansion of the software and services market over the forecast period. Several companies in the market offer high-end cellular imaging and analysis software for users to acquire, visualize, analyze, and share image data more quickly and easily, allowing them to devote more time to the search process.
Cell Biology, Stem Cell Biology, Developmental Biology, Drug Discovery, and Other Applications are some of the submarkets that make up this market. As more scientists investigate molecular interaction networks, the Cell Biology Segment is poised to become the industry leader in this area. Live cell imaging is used by cell biologists to deduce basic cellular structures and their interactions at the tissue level.
The use of live cell imaging to watch cells develop and learn about their physiological state bodes well for the future of the developmental biology subsector. Researchers in the field of developmental biology are afforded a unique window into cell division and growth as they observe embryonic development.
Market for live cell imaging worldwide: Key Developments
It was announced in July 2021 that Becton, Dickinson and Company would be launching their bdbiosciences.com web and e-commerce site, a digital marketplace designed to improve the convenience of online purchasing of BD research solutions such as clinical and single-cell multiomic products.
The Micro-mirror Array Lens System (MALS) in the ZEISS Visioner 1 digital microscope enables real-time, all-in-one focus, streamlining the imaging process, and increasing throughput, all of which were announced for release in January 2021 by ZEISS GROUP.
The bright field live cell imaging system CytoSMART Lux3 BR was introduced by CytoSMART Technologies in August 2021. Designed for label-free live-cell imaging, this compact bright field microscope features a high-resolution CMOS camera (6.4 megapixels).
Request for Enquiry or Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1081
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Live Cell Imaging Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Live Cell Imaging Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Explore More Report:
Veterinary diagnostic imaging market
Portable ultrasound bladder scanner market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837